Cargando…
Urinary Marinobufagenin in Patients with Non-Advanced Chronic Kidney Disease: A Cross-Sectional Study
Background and Objectives: The global prevalence of chronic kidney disease (CKD) is on the rise, posing important challenges for healthcare systems. Thus, the search for new factors potentially involved in the pathogenesis, progression and complications of early CKD remains urgent. Marinobufagenin (...
Autores principales: | Bolignano, Davide, Greco, Marta, D’Agostino, Mario, Cianfrone, Paola, Tripodi, Loredana, Misiti, Roberta, Zicarelli, Mariateresa, Ganino, Ludovica, Foti, Daniela Patrizia, Andreucci, Michele, Coppolino, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10456778/ https://www.ncbi.nlm.nih.gov/pubmed/37629682 http://dx.doi.org/10.3390/medicina59081392 |
Ejemplares similares
-
Marinobufagenin, Left Ventricular Hypertrophy and Residual Renal Function in Kidney Transplant Recipients
por: Bolignano, Davide, et al.
Publicado: (2023) -
New Insights on the Role of Marinobufagenin from Bench to Bedside in Cardiovascular and Kidney Diseases
por: Carullo, Nazareno, et al.
Publicado: (2023) -
miRNAs in Uremic Cardiomyopathy: A Comprehensive Review
por: D’Agostino, Mario, et al.
Publicado: (2023) -
Self-Reported Physical Inactivity and Mood Disturbances in End-Stage Kidney Disease (ESKD) Patients on Chronic Dialysis Treatment
por: Musolino, Michela, et al.
Publicado: (2023) -
Circulating Omentin-1, Sustained Inflammation and Hyperphosphatemia at the Interface of Subclinical Atherosclerosis in Chronic Kidney Disease Patients on Chronic Renal Replacement Therapy
por: Bolignano, Davide, et al.
Publicado: (2022)